Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

ISONIAZID Drug Profile

« Back to Dashboard

Which patents cover Isoniazid, and when can generic versions of Isoniazid launch?

Isoniazid is a drug marketed by Watson Labs, Ivax Sub Teva Pharms, Thepharmanetwork Llc, Hikma Intl Pharms, Mikart, Duramed Pharms Barr, Whiteworth Town Plsn, Panray, Halsey, Purepac Pharm, Sun Pharm Inds, Cmp Pharma Inc, Barr, Mk Labs, Sandoz Inc, Nexgen Pharma Inc, Impax Labs, Perrigo, Phoenix Labs Ny, Sandoz, Pharmavite, and Lilly. and is included in thirty-four NDAs.

The generic ingredient in ISONIAZID is isoniazid. There are five drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

Summary for Tradename: ISONIAZID

Patents:0
Applicants:22
NDAs:34
Suppliers / Packagers: see list29
Bulk Api Vendors: see list86
Clinical Trials: see list40
Patent Applications: see list8,030
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ISONIAZID at DailyMed

Pharmacology for Tradename: ISONIAZID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
ISONIAZID
isoniazid
TABLET;ORAL008499-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
ISONIAZID
isoniazid
TABLET;ORAL080270-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Impax Labs
ISONIAZID
isoniazid
TABLET;ORAL080153-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sandoz
ISONIAZID
isoniazid
TABLET;ORAL008678-002Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe
Perrigo
ISONIAZID
isoniazid
TABLET;ORAL083060-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot